Paliperidone extended-release: safety and tolerability from a metabolic profile perspective.
about
An update of safety of clinically used atypical antipsychotics.Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorder.Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.Modeling of prolactin response following dopamine D2 receptor antagonists in rats: can it be translated to clinical dosing?
P2860
Paliperidone extended-release: safety and tolerability from a metabolic profile perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Paliperidone extended-release: ...... metabolic profile perspective.
@en
type
label
Paliperidone extended-release: ...... metabolic profile perspective.
@en
prefLabel
Paliperidone extended-release: ...... metabolic profile perspective.
@en
P2860
P1476
Paliperidone extended-release: ...... metabolic profile perspective.
@en
P2093
Alfonso Rodríguez-Martínez
Carlos Guzmán Quilo
P2860
P304
P356
10.1007/S40261-013-0100-2
P577
2013-12-01T00:00:00Z